Home

spriedums Dibinātājs Modish parp hæmmere Metrs It īpaši bandinieks

The role of PARP inhibitors and BRCA mutation status in DNA repair and... |  Download Scientific Diagram
The role of PARP inhibitors and BRCA mutation status in DNA repair and... | Download Scientific Diagram

PARP inhibitors in combination with other therapeutics. Abbreviations:... |  Download Scientific Diagram
PARP inhibitors in combination with other therapeutics. Abbreviations:... | Download Scientific Diagram

PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells: Trends in  Cell Biology
PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells: Trends in Cell Biology

Focus on suppressive macrophages may boost effects of PARP inhibitors
Focus on suppressive macrophages may boost effects of PARP inhibitors

JCI - The evolving landscape of predictive biomarkers of response to PARP  inhibitors
JCI - The evolving landscape of predictive biomarkers of response to PARP inhibitors

PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms,  clinical development and future prospective (Review)
PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review)

PARP inhibitors in ovarian cancer - ScienceDirect
PARP inhibitors in ovarian cancer - ScienceDirect

PARP inhibitors: the journey from research hypothesis to clinical approval  | Personalized Medicine
PARP inhibitors: the journey from research hypothesis to clinical approval | Personalized Medicine

An Overview of PARP Inhibitors for the Treatment of Breast Cancer |  SpringerLink
An Overview of PARP Inhibitors for the Treatment of Breast Cancer | SpringerLink

The Latest Developments on PARP Inhibitors for Prostate Cancer Treatment
The Latest Developments on PARP Inhibitors for Prostate Cancer Treatment

PARP inhibitors in cancer treatment | OncologyPRO
PARP inhibitors in cancer treatment | OncologyPRO

Advances and perspectives of PARP inhibitors | Experimental Hematology &  Oncology | Full Text
Advances and perspectives of PARP inhibitors | Experimental Hematology & Oncology | Full Text

PARP inhibitors: Synthetic lethality in the clinic
PARP inhibitors: Synthetic lethality in the clinic

PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms,  clinical development and future prospective (Review)
PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review)

PARP inhibitors stumble in breast cancer | Nature Biotechnology
PARP inhibitors stumble in breast cancer | Nature Biotechnology

Cancers | Free Full-Text | Understanding Resistance Mechanisms and  Expanding the Therapeutic Utility of PARP Inhibitors
Cancers | Free Full-Text | Understanding Resistance Mechanisms and Expanding the Therapeutic Utility of PARP Inhibitors

Mechanism and current progress of Poly ADP-ribose polymerase (PARP)  inhibitors in the treatment of ovarian cancer - ScienceDirect
Mechanism and current progress of Poly ADP-ribose polymerase (PARP) inhibitors in the treatment of ovarian cancer - ScienceDirect

An Overview of PARP Inhibitors for the Treatment of Breast Cancer |  SpringerLink
An Overview of PARP Inhibitors for the Treatment of Breast Cancer | SpringerLink

How Do PARP Inhibitors Work In Cancer? | Dana-Farber Cancer Institute
How Do PARP Inhibitors Work In Cancer? | Dana-Farber Cancer Institute

Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating  Agents – A Potential Therapy for Cancer: Cancer Cell
Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents – A Potential Therapy for Cancer: Cancer Cell

Frontiers | Therapeutic Potential of Combining PARP Inhibitor and  Immunotherapy in Solid Tumors | Oncology
Frontiers | Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors | Oncology

PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current  practice and future directions | British Journal of Cancer
PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions | British Journal of Cancer